Uber Eats comes to Turkey via $700M Trendyol Go acquisition
Uber is expanding its presence in Turkey with its latest acquisition.
The ride-hail and delivery giant has acquired an 85% controlling stake in Trendyol Go, the online meal and grocery delivery business based in Istanbul, for about $700 million in cash. The deal gives Uber instant market share for Uber Eats in the country, where Uber currently only operates a ride-hail service.
Uber's acquisition announcement comes a day before the company is scheduled to report its first-quarter earnings. And with consumer spending projected to fall in 2025 due to President Trump's tariffs, investors will want reassurance that Uber is still poised for growth, even as the company recently pulled out of its $950 million bid for Delivery Hero's Foodpanda business in Taiwan.
Uber has been laying the groundwork for expansion in other arenas, too. It seems like every few weeks, Uber announces a new autonomous vehicle partnership across its ride-hail, delivery, and freight verticals.
Trendyol Go is the food delivery arm of parent company Trendyol Group, a fashion and retail e-commerce platform, which is majority-owned by Alibaba. The company said in a filing that it delivered more than 200 million orders in 2024, generating $2 billion in gross bookings, which was up 50% from the previous year. There are more than 90,000 restaurants and 19,000 couriers on its marketplace.
The acquisition is expected to close in the second half of 2025. When it does, users will be able to keep using the Trendyol Go app, and Uber will 'introduce key capabilities over the coming years from Uber Eats,' the company said.
TechCrunch has asked Uber for more information.
Techcrunch event
Exhibit at TechCrunch Sessions: AI Secure your spot at TC Sessions: AI and show 1,200+ decision-makers what you've built — without the big spend. Available through May 9 or while tables last.
Exhibit at TechCrunch Sessions: AI Secure your spot at TC Sessions: AI and show 1,200+ decision-makers what you've built — without the big spend. Available through May 9 or while tables last.
Berkeley, CA
|
BOOK NOW
Uber's latest acquisition comes as it struggles for market share back home in the U.S. due to competition from DoorDash. In February, Uber filed suit against DoorDash, alleging anticompetitive behavior. DoorDash has urged the courts to dismiss the case.
Earlier today, DoorDash announced two major acquisitions to expand its presence in Europe: The U.K.'s Deliveroo for $3.86 billion and SevenRooms for $1.2 billion.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
an hour ago
- Washington Post
Meta takes $15 billion stake in Scale AI in bid to catch competitors
Meta has agreed to pay $14.8 billion for a 49 percent stake in the AI data firm Scale AI in one of the biggest acquisitions the social media giant has made since its 2014 deal to buy WhatsApp, according to a person familiar with the matter. The arrangement with Scale AI, which could be announced as soon as Wednesday, will give the start-up's CEO, Alexandr Wang, a senior position at Meta leading a team focused on developing super intelligence, said the person, who spoke on the condition of anonymity to discuss private company matters.
Yahoo
an hour ago
- Yahoo
Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech
EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) ('Quest' or the 'Company'), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced today that Quest was not informed or consulted, opposes and will not support the recently announced acquisition by privately held South Korea-based OQPBIOM Inc. ('OQM') of a controlling interest in AdBioTech Co., Ltd. ('AdBioTech'), a public company listed on KOSDAQ in South Korea. OQM has announced that AdBioTech is the corporate vehicle through which it wishes to pursue the funding and advancement of its immunotherapy assets. As announced by Quest on June 2, 2025, as a result of the conversion of bonds, Quest has acquired a 26.25% share ownership interest in OQM and become its largest shareholder. OQM was established in April 2024 to conduct clinical trials for oregovomab, a novel ovarian cancer drug candidate, which was developed by Quest investee company, OncoQuest Inc., and sold in 2020, which ultimately resulted in Quest holding the bonds in OQM that were recently converted. Dr. Madi Madiyalakan, CEO of Quest, stated, "As the largest shareholder of OQM, we were never informed or consulted about OQM's acquisition of a controlling interest in AdBioTech and OQM's intention to use this vehicle to advance oregovomab." He added that Quest strongly opposes this acquisition and strategy, deeming it inappropriate for ensuring stable funding for oregovomab's clinical trials and not in the best interest of OQM or its shareholders. Quest is consulting with its advisors and evaluating its legal options. Any information or reports disseminated that suggest that Quest is supportive of OQM management in the implementation of this path and strategy for OQM is inaccurate. About Quest PharmaTech Inc. Quest PharmaTech Inc is a publicly traded, Canadian based biopharmaceutical company (QPT: TSX-V) developing products to improve the quality of life. The Company has a 42.5% ownership interest in OncoQuest Inc. which sold its immunotherapy technology assets to Korea-based Dual Industrial Co, Ltd. in April 2020. Quest also has a 23% ownership interest in OncoVent, a Chinese joint venture developing antibody-based immunotherapeutic products for cancer for the Greater China territory. Quest is also developing proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. AR 9.6 was licensed from University of Nebraska and currently is in late preclinical stage. To learn more, visit Forward Looking Statements This news release contains 'forward-looking information' within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as 'may', 'expect', 'likely', 'should', 'would', 'plan', 'anticipate', 'intend', 'potential', 'proposed', 'estimate', 'believe' or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions 'may' or 'will' happen. The forward-looking information contained herein is made as of the date of this press release and is based on assumptions management believed to be reasonable at the time such statements were made. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation, the risk factors that can be found in the Company's securities law filings which have been filed under the Company's SEDAR+ profile at Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. For further information: Dr. Madi R. Madiyalakan, CEO, Quest PharmaTech Inc. Tel: (780) 448-1400, E-mail: madi@ Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Yahoo
2 hours ago
- Yahoo
Afternoon Briefing: City could force Uber and Lyft to hike driver pay
Good afternoon, Chicago. Rideshare companies like Lyft and Uber could soon be forced to pay Chicago drivers more if an ordinance up for debate Thursday moves ahead, a change the companies say would cause the cost of rides to skyrocket for passengers. Ald. Michael Rodriguez, 22nd, said his measure would make sure rideshare drivers make more than minimum wage and get paid when they wait for and drive riders. But critics and the companies say the legislation will raise costs and could even put many drivers out of work. Here's what else is happening today. And remember, for the latest breaking news in Chicago, visit and sign up to get our alerts on all your devices. Subscribe to more newsletters | Asking Eric | Horoscopes | Puzzles & Games | Today in History Federal prosecutors announced today that they will retry state Sen. Emil Jones III on bribery charges after a jury in April deadlocked on all counts, leading to a mistrial. Read more here. More top news stories: Lawyers for R. Kelly claim wrongdoing by prosecutors, say imprisoned singer's life in danger $23.5M lawsuit settlement reached for family of technical surveyor killed in fall from Hyde Park scaffolding Illinois lawmakers ended their spring legislative session without finding a way to plug the gaping $771 million budget gap facing the region's mass transit systems next year. Thousands of jobs hang in the balance. Read more here. More top business stories: Apple unveils iOS 26 and a new 'liquid glass' design I-65 fiery truck crashes ignite conversation about tolling, expanding highway The longtime Sky star jokingly acknowledged her quiet exit in a Players Tribune column today as she formally announced her retirement from the WNBA — nearly three years after playing her final game for the Sky in September 2022. Read more here. More top sports stories: Column: Why Chicago Cubs star Pete Crow-Armstrong is content with just being himself How Chicago White Sox's Luis Robert Jr. is working to get going at the plate: 'I'm open to the suggestions' Anthony Mateos, who lives in Evanston and has just completed his junior year at Evanston Township High School, has compiled and published a terrific book titled 'Who We Are: Stories From the Chicago StreetWise Community.' Read more here. More top Eat. Watch. Do. stories: Steve Carell will speak at Northwestern University's 2025 commencement Sly Stone, leader of funk revolutionaries Sly and the Family Stone, dies at 82 The Marines that deployed to Los Angeles on orders from President Donald Trump have not yet been called to respond to the city's immigration protests and are there only to protect federal property, the Marine Corps commandant said. Read more here. More top stories from around the world: Defense Secretary Pete Hegseth faces sharp questions from Congress on deploying troops to Los Angles and Pentagon chaos President Donald Trump pushes ahead with his maximalist immigration campaign in face of LA protests
